Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Ariad Pharmaceuticals, Inc.    

ARIAD PHARMACEUTICALS, INC.
Mes dernières consult.
Most popular
Report
 SummaryNewsCompany 
Company
ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer.The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge,... 
More about the company
Latest news on ARIAD PHARMACEUTICALS, INC
2017 ARIAD PHARMACEUTICALS : Medinol Announces Appointment Of Harvey J. Berger, M.D.,..
2017 TAKEDA PHARMACEUTICAL : Japans Takeda acquires US cancer drug manufacturer ARIAD..
2017 ARIAD PHARMACEUTICALS INC : Entry into a Material Definitive Agreement, Completi..
2017 ARIAD PHARMACEUTICALS : Announces Submission of Marketing Authorization Applicat..
2017 ARIAD PHARMACEUTICALS INC : Other Events, Financial Statements and Exhibits (for..
2017 LAWSUIT FOR INVESTORS AGAINST ACQUIS : ARIA) Filed
2017 ARIAD PHARMACEUTICALS : Announces Submission of Marketing Authorization Applicat..
2017 ARIAD PHARMACEUTICALS : Enters into Definitive Agreement to Be Acquired by Taked..
2017 ARIAD PHARMACEUTICALS : Takeda to Acquire ARIAD Pharmaceuticals, Inc.
2017 TAKEDA PHARMACEUTICAL : Commences Cash Tender Offer for All Outstanding Shares o..
More news
Sector news : Bio Therapeutic Drugs
01/17 CELGENE : Conducts Deal Talks With Juno -- WSJ
01/16 CELGENE : in Talks to Buy Juno Therapeutics -- Update
01/16 CELGENE : in Talks to Buy Juno Therapeutics
01/12 Drugmakers see a pricing blueprint in an $850,000 gene therapy
01/12 SPARK'S PRICE FOR LUXTURNA BLINDNESS : Icer
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
2017 3 THINGS IN BIOTECH YOU SHOULD LEARN : April 30, 2017
2017 SNIPPET ROUNDUP : Aerie Stumbles On Safety; Stada Is Sold At Last
2017 First-Quarter Deal Making Shows Glimmers Of Growth
2017 WHAT TO WATCH IN Q2 : Upcoming Healthcare Regulatory Events
2017 Roche Looks Ready To Rule Another Cancer Niche
Managers
NameTitle
Christophe M. Bianchi Co-President
Paris Panayiotopoulos Co-President & Director
Timothy P. Clackson CSO, President-Research & Development
Nicholas Ventresca Chief Information Officer & Senior Vice President
Sarah J. Schlesinger Director
Sector and Competitors
1st jan.Capitalization (M$)
ARIAD PHARMACEUTICALS, INC.0
GILEAD SCIENCES14.10%105 754
VERTEX PHARMACEUTICALS4.76%39 951
REGENERON PHARMACEUTICALS-0.50%39 917
GENMAB10.50%11 762
EXELIXIS, INC.-9.57%8 284